MedPath

Prospective observational study to investigate the predictors of trastuzumab induced cardiac toxicity in breast cancer patients with perioperative chemotherapy

Not Applicable
Conditions
breast cancer
Registration Number
JPRN-UMIN000016962
Lead Sponsor
Graduate School of Medicine Kyoto University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

Patients unsuitable condition for this study judged by the investigator

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cardiomyopathy defined as incidence of cardiotoxicity, heart failure admission, and myocardial markers
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath